CaraVan Biologix, Inc. — Form D
CaraVan Biologix, Inc. of ANDOVER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-22. The offering totals $5.0M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-22
- Form: D
- Accession: 0001837437-22-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.7M
- Remaining: $3.3M
- Investors: 12
- Date of first sale: 2022-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438398
Issuer
- Name: CaraVan Biologix, Inc.
- CIK: 0001837437
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6 SUNNY LANE, ANDOVER, NJ, 07821
- Phone: 908-798-0147
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Llew Keltner | Director | Andover, NJ |
| Thomas Malcolm | Director | Andover, NJ |
| MICHAEL MARTINO | Director | NEW YORK, NY |
| Jeffrey Riley | Director | Nampa, ID |
| Thomas Malcolm | Executive Officer | Andover, NJ |
| Jeffrey Riley | Executive Officer | Nampa, ID |
| David Rowe | Executive Officer | BOCA RATON, FL |
Other filings by this issuer (1)
More